NCT01415791View on ClinicalTrials.gov

Oral Mucosal Absorption of ICI176,334-1

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Healthy
Interventions
DRUG

ICI176,334-1

Subject will receive single dose of ICI176,334-1

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT01415791 - Oral Mucosal Absorption of ICI176,334-1 | Biotech Hunter | Biotech Hunter